1. Home
  2. PRQR vs ELA Comparison

PRQR vs ELA Comparison

Compare PRQR & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • ELA
  • Stock Information
  • Founded
  • PRQR 2012
  • ELA 1965
  • Country
  • PRQR Netherlands
  • ELA United States
  • Employees
  • PRQR N/A
  • ELA N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • ELA Consumer Specialties
  • Sector
  • PRQR Health Care
  • ELA Consumer Discretionary
  • Exchange
  • PRQR Nasdaq
  • ELA Nasdaq
  • Market Cap
  • PRQR 232.8M
  • ELA 198.1M
  • IPO Year
  • PRQR 2014
  • ELA N/A
  • Fundamental
  • Price
  • PRQR $2.15
  • ELA $7.73
  • Analyst Decision
  • PRQR Strong Buy
  • ELA Strong Buy
  • Analyst Count
  • PRQR 8
  • ELA 1
  • Target Price
  • PRQR $8.88
  • ELA $9.00
  • AVG Volume (30 Days)
  • PRQR 368.1K
  • ELA 54.6K
  • Earning Date
  • PRQR 11-06-2025
  • ELA 11-04-2025
  • Dividend Yield
  • PRQR N/A
  • ELA N/A
  • EPS Growth
  • PRQR N/A
  • ELA 34.09
  • EPS
  • PRQR N/A
  • ELA 0.33
  • Revenue
  • PRQR $20,129,184.00
  • ELA $198,354,109.00
  • Revenue This Year
  • PRQR N/A
  • ELA $14.43
  • Revenue Next Year
  • PRQR N/A
  • ELA $2.60
  • P/E Ratio
  • PRQR N/A
  • ELA $22.41
  • Revenue Growth
  • PRQR 8.65
  • ELA 24.35
  • 52 Week Low
  • PRQR $1.07
  • ELA $5.10
  • 52 Week High
  • PRQR $4.62
  • ELA $7.88
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 49.40
  • ELA 64.40
  • Support Level
  • PRQR $1.91
  • ELA $6.95
  • Resistance Level
  • PRQR $2.50
  • ELA $7.50
  • Average True Range (ATR)
  • PRQR 0.16
  • ELA 0.33
  • MACD
  • PRQR -0.03
  • ELA -0.03
  • Stochastic Oscillator
  • PRQR 44.07
  • ELA 96.02

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

Share on Social Networks: